BRIAN JONES: Open Payments
NPI 1033174222 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,687 in 74 payments from 12 companies in 2025. Trend: 2023 $762 · 2024 $1,215 · 2025 $1,687
Food & beverage: $1,687
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $490 |
| Otsuka America Pharmaceutical, Inc. | 12 | $364 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $284 |
| Janssen Pharmaceuticals, Inc | 7 | $142 |
| Neurocrine BioSciences, Inc. | 4 | $93 |
| Lundbeck LLC | 4 | $90 |
| Alkermes, Inc. | 4 | $88 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ABILIFY MAINTENA, INVEGA SUSTENNA, INGREZZA, ARISTADA, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
